BrightSpring Health Services Lifts Full-Year Revenue Outlook to $14.73B-$15.23B After Strong Q1 Performance
BTSG has more than doubled off its 52-week low of $17.46 on elevated volume (2.1× avg).
Summary
BrightSpring Health Services significantly increased its full-year revenue guidance to a range of $14.73 billion to $15.23 billion and adjusted EBITDA to $795 million to $825 million, exceeding analyst expectations. This positive revision follows the company's strong first-quarter 2026 financial results, where profit from continuing operations surged to $74.3 million (34 cents per share) from $9.2 million a year prior, and revenue rose 26% to $3.62 billion, both beating analyst estimates. The stock is climbing on this news, reflecting investor confidence in the company's improved financial trajectory. This update provides a strong positive signal for future performance and could sustain the stock's momentum, especially as it trades near its 52-week high. Investors will watch for continued execution against this raised outlook.
At the time of this announcement, BTSG was trading at $52.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.1B. The 52-week trading range was $17.46 to $54.68. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.